Clinical Trials
All Clinical Trials - Page 22 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05440383Phase 3Completed
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Gonadorelin
- NCT05313529N/ACompleted
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
Liraglutide
- NCT05530577Phase 2Completed
Effects of Semaglutide on Nicotine Intake
Semaglutide
- NCT05766358N/ACompleted
Role Of Metabolic Adaptation In Weight Regain
Tirzepatide
- NCT05444153Phase 3Withdrawn
Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
Semaglutide
- NCT05658692Phase 4Unknown
Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
Thymosin-Alpha-1
- NCT04885634Phase 3Withdrawn
Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
Semaglutide
- NCT05473286N/AWithdrawn
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Semaglutide
- NCT05390892Phase 4Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Semaglutide
- NCT04599686N/AUnknown
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer
Gonadorelin
- NCT05371496Phase 4Completed
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
Semaglutide
- NCT06027567Phase 4Completed
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
Semaglutide
- NCT05340868N/ARecruiting
Genetics of the Acute Response to Oral Semaglutide
Semaglutide
- NCT05302596Phase 2Completed
Semaglutide Use in Elderly Obese Patients
Semaglutide
- NCT05545800Phase 3Unknown
Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
Liraglutide
- NCT05438186N/AWithdrawn
INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records
Liraglutide
- NCT05507476N/ACompleted
Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy
Desmopressin
- NCT05517590N/ACompleted
Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.
Desmopressin
- NCT05467033Phase 3Recruiting
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin
Desmopressin
- NCT05492305N/AUnknown
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
Semaglutide
- NCT05459844Phase 3Active Not Recruiting
A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs
Octreotide
- NCT05514535Phase 3Completed
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
Semaglutide
- NCT07028645N/AActive Not Recruiting
Uroflowmetry and Nocturnal Enuresis
Desmopressin
- NCT06411366Phase 1Completed
Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans
Follistatin
- NCT06962202N/ARecruiting
Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT
Desmopressin
- NCT05498610Phase 1Completed
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
Semaglutide
- NCT05419856Phase 1Completed
Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
Liraglutide
- NCT05486065Phase 2Completed
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
Semaglutide
- NCT05444569Phase 1Completed
A Study of LY3537021 in Healthy Participants
Liraglutide
- NCT05478252Phase 3Completed
A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
Semaglutide
- NCT05306340Phase 3Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
Gonadorelin
- NCT05433584Phase 4Active Not Recruiting
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Tirzepatide
- NCT07717866N/AActive Not Recruiting
Trifecta Research Study
Ipamorelin
- NCT06105229N/AUnknown
Clinical Value of Plasma Humanin in Acute Kidney Injury
Humanin
- NCT05469126Phase 1Completed
A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
Orforglipron
- NCT05379491N/ACompleted
Application of Linaclotide Capsule in Bowel Preparation for Patients at High Risk of Inadequate Bowel Preparation
Linaclotide
- NCT05479591N/AWithdrawn
A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
Liraglutide
- NCT05443334N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Semaglutide
- NCT05296798Phase 3Active Not Recruiting
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
Gonadorelin
- NCT05984134Phase 2Completed
Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction
TB-500
- NCT05263388Phase 3Completed
A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation
Gonadorelin
- NCT06390904Phase 2/Phase 3Active Not Recruiting
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
Gonadorelin
- NCT06379113Phase 2/Phase 3Recruiting
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Gonadorelin
- NCT05305794Phase 3Recruiting
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
Semaglutide
- NCT05442450Phase 4Unknown
Efficacy of Oral Semaglutide in Overweight or Obesity
Semaglutide
- NCT05445232Phase 1Completed
A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
Retatrutide
- NCT05161195Phase 4Active Not Recruiting
Roll-over Study to Allow Continued Access to Ribociclib
Gonadorelin
- NCT05413369Phase 3Completed
iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
Lixisenatide
- NCT07732218Phase 4Completed
Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial
Semaglutide
- NCT05421338Phase 1Completed
A Study in Healthy Men to Test How BI 456906 is Processed in the Body
Survodutide